Targeting PCSK9: Expanding knowledge and targeting new frontiers

Media formats available:

Insights and lessons from the ODYSSEY Outcomes trial: Which patients benefit most?
Insights and lessons from the ODYSSEY Outcomes trial: Which patients benefit most?
PCSK9i, changing practice in cardiology: The emerging story
Insights and lessons from the ODYSSEY Outcomes trial: Which patients benefit most?
- Prof. Ph. Gabriel Steg, MD
Extending the evidence: What did the FOURIER trial teach us on managing high-risk patients?
Extending the evidence: What did the FOURIER trial teach us on managing high-risk patients?
PCSK9i, changing practice in cardiology: The emerging story
Extending the evidence: What did the FOURIER trial teach us on managing high-risk patients?
- Prof. Marc S. Sabatine, MD

PACE-CME